Ciphergen develops, manufactures and markets the ProteinChip(R) System
that enables protein discovery, characterization and assay development to
provide researchers with a better understanding of biological functions at the
protein level. The ProteinChip System is a novel, enabling tool in the
emerging field of protein-based biology research, known as proteomics.
Proteomics provides a direct approach to understanding the role of proteins in
the biology of disease, monitoring of disease progression and the therapeutic
effects of drugs. Ciphergen believes proteomics will be a major focus of
biological research by enhancing the understanding of gene function and the
molecular basis of disease.
Copies of the prospectus relating to this offering may be obtained from SG
Cowen Securities Corporation, 1 Financial Square-27th Floor, New York, NY
10005 (FAX 212-425-5801 attn: Maryann Moccia).
SOURCE Ciphergen Biosystems, Inc.
CONTACT: investors, Sue Carruthers of Ciphergen Biosystems, Inc.,
510-505-2233, or scarruthers@ciphergen.com, or media, Richard Roose of GCI
Group, 415-356-9636, or rroose@gcigroup.com, for Ciphergen Biosystems, Inc.
ciphergen.com
I started looking at them today. Lots of scientific paper links on the web site. Not sure about the patent issues. I have not spent too much time looking yet.
Mentioned in the follow on post of an article from Scientific American.
Jim |
